Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Wed, 21st Apr 2021 12:08

(Alliance News) - Stock prices in London were continuing to recover from Tuesday's steep losses at midday on Wednesday against a backdrop of rising global coronavirus infections, while Netflix will be in focus after missing subscriber targets.

Countries around the world are urgently working to accelerate vaccination campaigns and revive their pandemic-ravaged economies, with new variants of Covid-19 driving unprecedented infection numbers in some of the worst-hit nations, including Japan and India.

The FTSE 100 index was up 16.95 points, or 0.3%, at 6,876.65 at midday Wednesday. The flagship index closed down 140.21 points, or 2.0%, at 6,859.87 on Tuesday.

The mid-cap FTSE 250 was up 20.50 points, or 0.1%, at 22,129.05. The AIM All-Share index was up 0.2% at 1,240.55.

The Cboe UK 100 index was up 0.3% at 684.32. The Cboe 250 was up 0.1% at 19,774.59. The Cboe Small Companies was up 0.2% at 14,366.64.

In mainland Europe, the CAC 40 index in Paris and the DAX 30 in Frankfurt were up 0.1% and 0.3% respectively.

"European markets are in recovery mode today, with stocks turning upward to regain lost ground after sharp declines yesterday. Markets are caught between optimism over vaccination progress at home, and the fact that global efforts to combat the pandemic remain reliant upon economic restrictions until vaccines are widespread," said IG Group's Josh Mahony.

In the FTSE 100, Hikma Pharmaceuticals was the best performer, up 2.9% after the drugmaker said it resumed the launch of its generic version of GlaxoSmithKline's Advair Diskus in the US. The drug is is used to treat people with asthma and people with chronic obstructive pulmonary disease. Glaxo shares were up 1.9%.

BP and Royal Dutch Shell 'A' and 'B' shares were up 2.2%, 2.1% and 2.0% respectively after Deutsche Bank started coverage on the oil majors with Buy ratings. Deutsche also rated peers ENI and Total as Buy. ENI was up 0.6% in Milan and Total up 1.0% in Paris.

At the other end of the list of London large-caps, Just Eat Takeaway.com was still the worst performer at midday, down 4.8%, amid competition concerns.

Uber Technologies is attempting to break what it called Just Eat Takeaway's "monopolistic" stranglehold on the German food delivery market, the Financial Times reported.

Shares in the San Francisco, California-based firm were up 0.7% in pre-market trade in New York.

According to the newspaper, Uber Eats will launch in Germany for the first time over the next few weeks, starting in Berlin, in its biggest entry to a new country since 2018.

Bunzl was 2.8% lower. The distribution and services firm said its "diversified and resilient" business model delivered good overall growth during the first quarter of 2021, despite the boost from supplying PPE during the virus pandemic starting to fall away.

Revenue was up 5.4% at actual exchange rates and 10% at constant exchange rates. Underlying revenue growth at constant exchange rates increased by 1.4%, in line with expectations.

In addition, Bunzl said adjusted operating margin continued to be supported by demand for Covid-19 related products. The company delivered personal protective equipment to businesses to help combat the pandemic.

Looking ahead, Bunzl said guidance remains unchanged. At constant exchange rates, Bunzl continues to expect robust revenue growth in 2021 compared to the prior year, after excluding larger Covid-19 related orders, which contributed GBP550 million of revenue in 2020.

Antofagasta was 0.5% lower. The Chilean miner said copper production in the first quarter was in line with guidance at 183,000 tonnes, 5.7% lower than in the same quarter in 2020 and 5.0% lower than in the fourth quarter, mainly due to expected reduced grades at the Los Pelambres mine.

Gold production was 59,100 ounces in the first quarter, 9.2% lower than in the same period in 2020 but 8.0% higher than in the fourth quarter, mainly due to changes in grade at the Centinela mine.

Looking ahead, Antofagasta said full-year guidance is unchanged at 730,000 tonnes to 760,000 tonnes of copper at a net cash cost of USD1.25 per pound and capital expenditure of USD1.6 billion.

Peer BHP was down 0.7% after the Anglo-Australian miner said it is bringing new supply in copper, petroleum and iron ore, while coal production guidance has been lowered after wet weather hit operations.

At the end of March, BHP said it had four major projects under development in petroleum, iron ore and potash, with a combined budget of USD8.5 billion over the life of the projects.

Both metallurgical coal and energy coal production guidance were lowered due to wet weather hitting numerous sites over the last few months.

Metallurgical coal production guidance was reduced to between 39 million tonnes and 41 million tonnes, having previously been set at between 40 million tonnes and 44 million tonnes.

Energy coal guidance was lowered to between 18 million tonnes and 20 million tonnes, from between 21 million tonnes and 23 million tonnes.

The pound was quoted at USD1.3928 at midday on Wednesday, lower from USD1.3940 at the London equities close Tuesday.

On the economic front, UK inflation rose slightly in March according to the latest figures from the Office for National Statistics, but the annual print just missed market estimates.

On an annual basis, UK consumer prices rose 0.7% in March, accelerating from a rise of 0.4% in February. However, the latest reading was just shy of market consensus, cited by FXStreet, for an 0.8% increase.

On a monthly basis, consumer prices grew 0.3% in March, rising slightly from inflation of 0.1% in February. The figure was in-line with the consensus estimate.

Inflation remains well below the Bank of England's target of 2.0%. The central bank's next interest rate decision is on May 6. However, consumer prices are expected to rise as the UK economy reopens.

"UK inflation is set to rise above 2% this year, predominantly on energy-related tailwinds... We suspect CPI is more likely to drift lower, suggesting the pressure on the Bank of England to tighten policy again will be fairly modest," said analysts at ING.

The euro was priced at USD1.2002, down from USD1.2035 late Tuesday in London. Against the yen, the dollar was quoted at JPY108.09, marginally higher from JPY108.03.

Brent oil was trading at USD65.92 a barrel Wednesday at midday, up from USD65.71 late Tuesday. Gold was quoted at USD1,788.71 an ounce, higher from USD1,776.45.

US stock market futures were pointed to a lower open, deepening their retreat from Tuesday's losses.

The Dow Jones Industrial Average and the S&P 500 index were both called down 0.1% and the Nasdaq Composite was seen opening 0.2% lower.

Netflix will be in focus after the video streaming services provider missed membership targets.

Revenue for the first quarter of 2021 grew 24% year-on-year to USD7.16 billion from USD5.77 billion, while net income surged to USD1.71 billion from USD709 million. Earnings per share also jumped to USD3.75 from USD1.57. The revenue figure was in line with the Los Gatos, California-based firm's beginning-of-quarter forecast, it said, while operating profit and margin reached all-time highs, at USD1.96 billion and 27.4% respectively.

However, Netflix said it finished the quarter with 208 million paid memberships, up 14% on a year ago but below its guidance of 210 million. Paid net additions of 4.0 million were below its 6.0 million guidance.

Looking ahead to the second quarter, Netflix expects revenue to rise 2.3% quarter-on-quarter to USD7.30 billion. However, net income is expected to slip to USD1.44 billion, down 16% on the first quarter's result.

Netflix shares were down 8.0% in New York pre-market trade.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2023 09:39

LONDON BROKER RATINGS: Jefferies raises John Wood to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
3 Aug 2023 15:45

UK dividends calendar - next 7 days

Friday 4 August 
Burberry Group PLCdividend payment date
Bytes Technology Group PLCdividend payment date
Bytes Technology Group PLCspecial dividend payment date
CC Japan Income & Growth Trust PLCdividend payment date
CT UK High Income Trust PLCdividend payment date
Ferguson PLCdividend payment date
Global Smaller Cos Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan European Discovery Trust PLCdividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Mitie Group PLCdividend payment date
NewRiver REIT PLCdividend payment date
Norcros PLCdividend payment date
North American Income Trust PLCdividend payment date
Palace Capital PLCdividend payment date
Premier Miton Group PLCdividend payment date
Regional REIT Ltddividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Supermarket Income REIT PLCdividend payment date
Twentyfour Income Fund Ltddividend payment date
Value & Indexed Property Income Trust PLCdividend payment date
Vodafone Group PLCdividend payment date
Vp PLCdividend payment date
Workspace Group PLCdividend payment date
Monday 7 August 
no events scheduled 
Tuesday 8 August 
no events scheduled 
Wednesday 9 August 
National Grid PLCdividend payment date
Record PLCdividend payment date
Thursday 10 August 
abrdn New Dawn Investment Trust PLCex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
Avon Protection PLCex-dividend payment date
Barclays PLCex-dividend payment date
BP PLCex-dividend payment date
Domino's Pizza Group PLCex-dividend payment date
Fresnillo PLCex-dividend payment date
Greencoat Renewables PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
Halfords Group PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
HSBC Holdings PLCex-dividend payment date
IMI PLCex-dividend payment date
Impax Environmental Markets PLCex-dividend payment date
Informa PLCex-dividend payment date
IP Group PLCex-dividend payment date
Irish Residential Properties REIT PLCex-dividend payment date
Lindsell Train Investment Trust PLCex-dividend payment date
LMS Capital PLCex-dividend payment date
Majedie Investments PLCex-dividend payment date
Man Group PLCex-dividend payment date
NatWest Group PLCex-dividend payment date
PayPoint PLCex-dividend payment date
Pearson PLCex-dividend payment date
PRS REIT PLCex-dividend payment date
Quartix Technologies PLCex-dividend payment date
Reach PLCex-dividend payment date
Residential Secure Income PLCex-dividend payment date
Rio Tinto PLCex-dividend payment date
Safestore Holdings PLCdividend payment date
Scottish American Investment Co PLCex-dividend payment date
Segro PLCex-dividend payment date
Shell PLCex-dividend payment date
Speedy Hire PLCex-dividend payment date
Spirent Communications PLCex-dividend payment date
Standard Chartered PLCex-dividend payment date
Target Healthcare REIT PLCex-dividend payment date
Taylor Maritime Investments Ltdex-dividend payment date
Treatt PLCdividend payment date
Tritax Big Box REIT PLCex-dividend payment date
Vanquis Banking Group PLCex-dividend payment date
Vh Global Sustainable Energy Opportunities PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Aug 2023 09:28

Hikma posts higher interim revenue; ups guidance for Generics business

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it expects a higher full year performance from its Generics business amid interim revenue growth, but reported a drop in profit.

Read more
3 Aug 2023 07:51

Hikma lifts guidance for generics business

(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.

Read more
27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Friday 28 July 
AstraZeneca PLCHalf Year Results
AIB Group PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Rightmove PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
Vanquis Banking Group PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Bank of Ireland Group PLCHalf Year Results
GlobalData PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Ricardo PLCTrading Statement
Senior PLCHalf Year Results
Spectris PLCHalf Year Results
Tuesday 1 August 
BP PLCHalf Year Results
Coats Group PLCHalf Year Results
Diageo PLCFull Year Results
Domino's Pizza Group PLCHalf Year Results
Filtronic PLCFull Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Metro Bank PLCHalf Year Results
NWF Group PLCFull Year Results
Robert Walters PLCHalf Year Results
Staffline Group PLCHalf Year Results
System1 Group PLCFull Year Results
Travis Perkins PLCHalf Year Results
Virgin Wines UK PLCTrading Statement
Weir Group PLCHalf Year Results
XP Power LtdHalf Year Results
Wednesday 2 August 
BAE Systems PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Haleon PLCHalf Year Results
Genel Energy PLCHalf Year Results
Ibstock PLCHalf Year Results
IP Group PLCHalf Year Results
Kerry Group PLCHalf Year Results
Permanent TSB Group Holdings PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Thursday 3 August 
Coca-Cola Europacific Partners PLCHalf Year Results
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCTrading Statement
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCQ1 Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 17:08

Commodity-heavy FTSE 100 lifted by Anglo American, China stimulus hopes

Anglo American shines after production update

*

Read more
20 Jul 2023 11:43

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.

Read more
20 Jul 2023 09:54

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.

Read more
20 Jul 2023 08:53

Hikma surges after tornado damages Pfizer injectables plant

(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.

Read more
12 Jul 2023 09:27

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
8 Jun 2023 12:03

Director dealings: Hikma non-exec invests, LSE Group share buyback rolls on

(Sharecast News) - Hikma Pharmaceuticals was among those on the list of director buys on Thursday, after a non-executive director added almost £27k worth of shares to his holding.

Read more
22 May 2023 09:23

LONDON BROKER RATINGS: Citigroup cuts Sainsbury to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
3 May 2023 16:16

Broker tips: HSBC, Hikma, Pearson

(Sharecast News) - Berenberg upgraded HSBC to 'buy' from 'hold' on Wednesday, keeping the price target at 780p, as it said the bank's return on tangible equity of around 13% and attractive growth potential are undervalued.

Read more
3 May 2023 12:56

RBC Capital lifts Hikma price target, reiterates 'outperform'

(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.